Clinical Trials Browser

Phase 3 × Completed × ravulizumab × Clear all

NCT03920293 2024-05-28

Safety and Efficacy Study of Ravulizumab in Adults With Generalized Myasthenia Gravis

Phase 3 Completed

175 enrolled 15 charts

Myasthenia Gravis